Fiche centre
Linear Clinical Research
Nedlands — Australia
Essais liés3clinical trials
VilleNedlandslocalisation
PaysAustralialocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06205628
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Tacabrutideg | Cancer | Phase 1/2 | NCT05006716 | CaDAnCe-101 — A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies | RECRUITING |
| ADX-850 | Hypertension | Phase 1 | NCT06205628 | Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension | ACTIVE_NOT_RECRUITING |
| PIPE-307 | SEP | Phase 1 | NCT04725175 | Phase I Study Evaluating Safety and Tolerability of Escalating Single and Multiple Doses of of PIPE-307 and Food Effect in Healthy Volunteers | COMPLETED |